"Trade what you see not what you think" Bullish Sentiment

Interest in this market

ABBV stock- Strong area of support that rallied up to the $125s which clearly shows institutional interest within the 94-98 zone.

1-3 risk to reward whilst still keeping an eye on 85s

Reason for opposing catalyst
Retail Investors had all the there chips in hoping for accelerated approval for the drug Rova-T (Drug) which they forked out just shy of $6 billion for Stemcentrx, (Defeating the purpose of the acquisition)

Risk management
Cut losses quickly
Wait till price action breaches more into the level to buy cheaper